
A powerful decision support system for optimizing supply chain challenges and opportunities.
- Rapid drug information search
- Drug shortages & discontinuations
- Drug safety data
- Details & results for clinical trials
- Drug & indication approvals
- Orange Book patents & exclusivity
- Key people
- Details on companies
Request a Demo
Questions before requesting a demo?
Contact us by email.
Who This Is For
- Health-system pharmacy, procurement, and supply-chain teams
- Market access and HEOR consultants
- Regulatory affairs and compliance teams
- Pharma and biotech analytics groups
- Academic and health-outcomes researchers
What’s Included
- Drug shortages (current and historical), with NDC-level detail
- FDA Orange Book (patents, exclusivity, AB ratings)
- FDA Purple Book (biosimilars, interchangeability)
- FDA warning letters
- Product discontinuations
- NDC-level product characteristics (route, form, manufacturer, class)
- Monthly or quarterly historical snapshots
- Downloadable tables (CSV / Excel) and summary PDFs
Why Teams Use The Pharma Report
Most organizations still manually pull, clean, and reconcile FDA data across multiple sources. This database consolidates those datasets into a single, analyzable reference with historical depth.
The result: less manual work, fewer data gaps, and faster analysis.
